title: [Hepatocyte growth factor did not enhance the effects of bone marrow-derived mesenchymal stem cells transplantation on cardiac repair in a porcine acute myocardial infarction model].
abstract: OBJECTIVE
  To evaluate the impact of combined therapy with transplanting bone marrow-derived mesenchymal stem cells (BM-MSCs) via noninfarct-relative artery and hepatocyte growth factor (HGF) in a porcine myocardial infarction (MI) model.
  
  
  METHODS
  BM-MSCs were obtained from pig bone marrow, expanded in vitro with a purity of > 50%. MI was induced by ligating the distal left anterior descending artery in pigs. Eighteen animals received BM-MSCs cells (5 x 10(6)/ml, n = 6), BM-MSCs cells (5 x 10(6)/ml) plus HGF (4 x 10(9) pfu, n = 6) or equal volume culture medium (IMDM) via non-infarct-related artery at four weeks after MI. Gated myocardial perfusion imaging and coronary angiography were performed before and four weeks after transplantations. Histological examination was also performed 4 weeks after transplantation.
  
  
  RESULTS
  LVEF measured by gated myocardial perfusion imaging was similar among groups before transplantation and significantly increased in BM-MSCs (45 +/- 3 vs. 34 +/- 2%, P < 0.05) or BM-MSCs + HGF (46 +/- 6 vs. 34 +/- 3%, P < 0.05) treated animals while remained unchanged in IMDM (30 +/- 3 vs. 32 +/- 2%) treated animals 4 weeks post transplantation. Similarly, capillary density was also significantly higher and myocardial perfusion defect scores significantly decreased in BM-MSCs or BM-MSCs + HGF treated hearts than that in IMDM treated hearts. However, all these changes were similar between BM-MSCs and BM-MSCs + HGF groups. Rentrop score was similar before and 4 weeks after transplantation among various groups.
  
  
  CONCLUSIONS
  HGF in combination with BM-MSCs transplantation did not enhance the cardiac repair effects of BM-MSCs transplantation alone and BM-MSCs transplantation did not improve collateral circulation in this model.
authors.affiliation: Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
authors.forename: Dong-chao
authors.initials: DC
authors.lastname: Ma
authors.forename: Zhi-jian
authors.initials: ZJ
authors.lastname: Yang
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.forename: Shun-lin
authors.initials: SL
authors.lastname: Xu
authors.forename: Yu-Qing
authors.initials: YQ
authors.lastname: Zhang
authors.forename: Fang
authors.initials: F
authors.lastname: Zhou
authors.forename: Bo
authors.initials: B
authors.lastname: Chen
authors.forename: Zhao-qiang
authors.initials: ZQ
authors.lastname: Xu
authors.forename: Ke-jiang
authors.initials: KJ
authors.lastname: Cao
authors.forename: Wen-zhu
authors.initials: WZ
authors.lastname: Ma
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D003097:Collateral Circulation; D004195:Disease Models, Animal; D017228:Hepatocyte Growth Factor / Q000627:therapeutic use*; D045164:Mesenchymal Stem Cell Transplantation; D009203:Myocardial Infarction / Q000601:surgery / Q000628:therapy*; D013552:Swine
chemical_list: D017228:Hepatocyte Growth Factor